These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22920483)

  • 1. Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
    Saklani P; Skanes A
    Curr Cardiol Rev; 2012 Nov; 8(4):302-9. PubMed ID: 22920483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in the antiarrhythmic therapy of atrial fibrillation].
    Simon H; Simon Demel K; Ritscher G; Turschner O; Brachmann J
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):212-6. PubMed ID: 21107985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?
    Conde D; Costabel JP; Alves de Lima A
    Can J Cardiol; 2013 Oct; 29(10):1330.e11-1330.e12. PubMed ID: 23639270
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
    Adlan AM; Lip GY
    Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
    Camm AJ; Savelieva I
    J Interv Card Electrophysiol; 2008 Oct; 23(1):7-14. PubMed ID: 18523740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New developments in the antiarrhythmic therapy of atrial fibrillation].
    Ravens U
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):41-6. PubMed ID: 24496483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone-current status in management of atrial fibrillation.
    Manakshe G; Rao BH
    Indian Heart J; 2012; 64(2):182-6. PubMed ID: 22572497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation.
    Koskinas KC; Fragakis N; Katritsis D; Skeberis V; Vassilikos V
    Europace; 2014 Jul; 16(7):973-9. PubMed ID: 24473502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
    Burashnikov A; Sicouri S; Di Diego JM; Belardinelli L; Antzelevitch C
    J Am Coll Cardiol; 2010 Oct; 56(15):1216-24. PubMed ID: 20883928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antiarrhythmic drugs for the treatment of atrial fibrillation].
    Botto GL; Russo G; Mariconti B; Pentimalli F; Campana C
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):10S-15S. PubMed ID: 23096368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on current care guidelines: atrial fibrillation].
    ;
    Duodecim; 2011; 127(5):506-8. PubMed ID: 21491757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone for atrial fibrillation: a new therapeutic agent.
    Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR
    Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.